Please log in to determine if you are eligible to purchase PT Programs.
CAP/ACMG CARDIOMYOPATHY SEQUENCING PANEL - CMSP
CMSP
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Analyte/Procedure Challenges per Shipment Number of Shipments
Cardiomyopathy sequencing panel 3 Two shipments per year

Additional Information

  • This proficiency challenge is for laboratories performing gene panels, exome sequencing, and whole genome sequencing to detect germline variants associated with inherited forms of cardiomyopathy.
  • Participants will be asked to identify variants in the following genes: MYBPC3, MYH7, TNNI3, TNNT2, and TPM1.

Program Information

  • Three 80.0-μL purified extracted DNA specimens (50 ng/μL)
  • Results for this program must be submitted online through e-LAB Solutions Suite

Shipping Schedule

  • Shipment A: July 14
  • Shipment B: October 13






Customers Who Bought This Item Also Bought
NGS UNDIAGNOSED DISORDERS-EXOME
VIEW DETAILS >
NEXT-GENERATION SEQUENCING - GERMLINE
VIEW DETAILS >
NGS BIOINFORMATICS SOMATIC VALIDATED MATERIAL
VIEW DETAILS >